זימקסיד

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

GATIFLOXACIN 0.5 %W/V

MAH:

ALLERGAN ISRAEL LTD

ATC_code:

S01AX21

pharmaceutical_form:

OPHTHALMIC SOLUTION

administration_route:

OCULAR

manufactured_by:

ALLERGAN INC., USA

therapeutic_group:

GATIFLOXACIN

therapeutic_indication:

Zymaxid is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Aerobic Gram- Negative Bacteria : Haemophilus influenzae, Aerobic Gram-positive Bacteria: Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus mitis group*, Streptococcus oralis *, Streptococcus pneumoniae. Efficacy for this organisms was studied in fewer than 10 infections.

authorization_date:

2012-11-01